Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Kailera Therapeutics, Inc. (KLRA) since 2026 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Kailera Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 2096997.
Total stock buying since 2026: $318,750,016.
Total stock sales since 2026: $0.
Total stock option exercises since 2026: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2026 | 19,921,876 | $318,750,016 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2026-04 | 19,921,876 | $318,750,016 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2026-04-20 | Bcpe Perseus Investor, Lp | Buy | 8,398,438 | 16.00 | 134,375,008 |
| 2026-04-20 | Bcls Fund Iv Investments, L.p. | Buy | 1,562,500 | 16.00 | 25,000,000 |
| 2026-04-20 | Kaplan Andrew T. | Buy | 8,398,438 | 16.00 | 134,375,008 |
| 2026-04-20 | Koppel Adam | Buy | 1,562,500 | 16.00 | 25,000,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of KLRA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Kailera Therapeutics, Inc. (symbol KLRA, CIK number 2096997) see the Securities and Exchange Commission (SEC) website.